SlideShare: Avoiding the Most Common Challenges Faced by Existing Pharma Co-Promotions

Existing pharma co-promotions face challenges that can threaten their success and longevity if not addressed. Learn about the these challenges and methods our expert co-promotion team has applied to remedy them.

How RxC International Can Help

RxC International has extensive experience working with biopharmaceutical companies seeking to maximize the value of existing co-promotion programs.  We leverage our proprietary co-promotion effectiveness diagnostic framework to identify areas for realignment and develop an action plan for overcoming co-promotion challenges.  To learn more about our co-promotion services, request an evaluation of your co-promotion partnerships, or download our newly published co-promotion white paper, please visit us or email Frank Koos, Head of Business Development, at

About the Authors

James Hoyes is an Executive Partner at RxC International where he specializes in corporate development and commercializing pharmaceutical and biotech products.  Prior to joining RxC International, Jim served as President of EMD Serono and held other leadership positions with several leading biopharma companies.

Subbarao Jayanthi, Managing Partner of RxC International, has over 20 years of strategic consulting and operational experience in the life sciences sector.  His areas of expertise include corporate strategy, life cycle management, and M&A.  Subbarao has authored several books to help biopharma companies navigate the complexity of each stage of the value chain.